Bayer completes the sale of Dr. Scholl’s to the Yellow Wood Partners fund for $585 million

The chemical and pharmaceutical group Bayer has completed the sale of the entire business of Dr. Scholl’s, a brand specialized in podiatry products, to the US investment fund Yellow Wood Partners for 585 million dollars, according to a statement.

“We believe that Yellow Wood Partners is the right owner to continue investing and growing the Dr. Scholl’s brand,” said Heiko Schipper, a Bayer board member and head of the Consumer Health area.

The German company acquired Dr. Scholl’s in 2014 as part of the purchase of the MSD consumer health products business, for which it disbursed $14.2 billion.

Last July, Bayer reported the agreement for the sale of Dr. Shcoll’s to Yellow Wood Partners. In 2018, Dr. Scholl’s recorded a turnover of 234 million dollars in the United States.

After the acquisition by Yellow Wood, the brand will become an independent company, in which the fund will invest “in all aspects of the business” to “boost” growth and profitability.

Sign Up for Our Newsletters

You May Also Like

Google celebrates its 20th anniversary with its most popular searches

Google celebrates the anniversary of its homonymous search engine, which has been…

British Petrofac will sell 49% of its operations in Mexico

British oil services provider Petrofac Ltd said on Monday it has agreed…

Brazilian restaurant operator IMC merges with Pizza Hut and KFC franchisor in Brazil

Brazilian restaurant operator International Meal Company Alimentacao SA (IMC) reached an agreement…